header
 

banner rdc

---------------------------------

The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System.


---------------------------------

banner norvasc

---------------------------------

Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information

---------------------------------



banner rdc

This system allows you to search for relevant content from today’s leading providers in the world of continuing education, maintain your personal curriculum, bank your continuing education credits (both online and offline), track and print your professional transcript and more…


bullet Pharmacist e-Link CE Spotlight

thumbnail What's New in GERD Therapy: A Case-Based Approach
Gastroesophageal reflux disease (GERD) is estimated to be the most common upper gastrointestinal (GI) disorder in the Western World. While approximately 7% of the population reports daily heartburn, up to 20% complain of weekly symptoms consistent with the disease.
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

thumbnail Motivational Interviewing: An Introductory Program for Community Health Care Professionals
Counseling patients is of primary importance to their best outcomes and continued therapy so the quality of the interaction between the patient and healthcare professional is of vital importance. This program will provide a basic introduction to motivational interviewing and then describe key strategies that health care professionals can use during their patient consultations.
Commercial Support Provided by Genzyme.

bullet Other Featured CE

thumbnail

Advances in the Management of Cardiovascular Disease: Understanding the Effect of the Renin-Angiotensin-Aldosterone System
This 1-hour audio lecture activity, including a patient case study review, is designed to provide managed markets physicians, pharmacists, and nurses with education on the clinical and economic burden or cardiovascular disease, with a focus on the most frequent comorbidities that lead to high risk for cardiovascular events and mortality.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals.

thumbnail

Counseling Patients on the Use of Pancreatic Exocrine Insuffiency (PEI) Drug Products: An Update
Pancreatic extract drug products are indicated in the treatment of exocrine pancreatic insufficiency, a potential complicating factor in cystic fibrosis, chronic pancreatitis, pancreatic tumors, or pancreatectomy. The safe and effective use of pancreatic enzyme drug products requires standardized enzyme activity and consistent drug therapy.
Commercial Support Provided by Solvay Pharmaceuticals, Inc.

thumbnail

Generic Substitution and Therapeutic Equivalence of Antiepileptic Drugs: Clinical and Pharmacoeconomic Issues in Epilepsy Treatment
Generic drug substitution is complex and often poorly understood. With antiepileptic drugs (AEDs), the therapeutic range over which they are effective may be narrow and may represent suboptimal care. This program will give an overview of important issues associated with generic substitution of AEDs.
Commercial Supporter is Abbott Laboratories.
  Please click here to forward this newsletter to a friend